KYC / AML for Pharmaceuticals & Life Sciences

KYC / AML in Pharmaceuticals & Life Sciences environments carries requirements that go beyond the framework's general provisions. The specific operations of Pharmaceuticals & Life Sciences organizations — their data processing scale, their regulatory relationships, and their operational dependencies — create compliance obligations that engineering teams must address at the architecture level. Generic KYC / AML compliance that ignores the Pharmaceuticals & Life Sciences context will produce a system that passes audit by a framework-generalist but fails review by an industry-specialist examiner.

Our teams deploy in Pharmaceuticals & Life Sciences environments with KYC / AML compliance built into the architecture from the first design decision. The compliance controls are not a layer added to an existing system — they are implemented as first-class components that generate evidence continuously as the system operates. The result is a system that is compliant on deployment day, remains compliant as it evolves, and produces audit evidence without manual assembly.

We implement KYC / AML compliance for Pharmaceuticals & Life Sciences clients by mapping the framework's requirements to the specific operational context of Pharmaceuticals & Life Sciences organizations before writing application code. Controls are implemented through infrastructure-as-code, enforced automatically by ALICE at every commit, and documented through automated evidence generation pipelines. The result is a KYC / AML-compliant Pharmaceuticals & Life Sciences system delivered on a fixed-price timeline.

Ready to build KYC / AML compliance into your Pharmaceuticals & Life Sciences system?

We build compliance architecture for Pharmaceuticals & Life Sciences organizations — KYC / AML and the full Pharmaceuticals & Life Sciences compliance landscape — from the first infrastructure decision. Fixed price. Production delivery. No discovery phase.